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Stable assemblies of proteins, known as protein complexes, execute a large
fraction of cellular processes required to sustain life. A functional and mechanistic
understanding of these assemblies will provide a more comprehensive understand-
ing of an organisms genes and elucidate a more complete picture of cellular pro-
cesses, particularly those involved in development, aging and disease. While recent
progress has mapped protein complexes in budding yeast and some bacteria, efforts
in animals are restricted to subsets of the proteome, leaving most animal protein
complexes undetermined. Co-fractionation offers compelling efficiency gains in
identifying pairwise protein interactions and complexes, but it requires significant
computational efforts to fully exploit. In this work, I describe the computational
methods and infrastructure I developed to identify conserved protein interactions
and complexes from a massive set of mass spectrometry data from nine species
and the computational and biological analysis I performed with my collaborators.
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These efforts include building a mostly automated pipeline to process and inte-
grate large quantities of mass spectrometry data from multiple species and devel-
oping improved methods to predict co-complex interactions and cluster them into
complexes. The conserved animal complex map produced using this pipeline and
methodology has already yielded dividends in supporting biological discoveries.
Scaling the approach more broadly will enable rapid mapping of the previously
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Chapter 1
Background: protein interactions, complexes and
networks
1.1 Genes to Genomes
It is striking to recall that publication of the first eukaryotic genome, the
yeast S. cerevisiae, occurred only twenty years ago (Goffeau et al., 1996). At only
twelve million base pairs, the yeast genome is dramatically smaller than the hu-
man genome at three billion base pairs. Yet, publication of the initial draft (>90%
complete) of the human genome followed only five years later (HGP, 2001). The
genomic revolution in the ensuing years, driven in part by dramatically decreasing
sequencing costs, yielded the publication of a growing set of organisms, from mice
to flies to worms, with the list now including hundreds of organisms in the animal
kingdom alone.
Molecular biology and genetics were thriving fields of research prior to the
emergence of fully-sequenced genomes. However, full knowledge of the genomes
of many organisms was a boon for research in molecular and cellular biology. By
providing a complete ingredients list, this was a critical step towards unravelling
the underlying substrates for biological processes. Full genomes provided biolo-
gists with a starting point for many additional questions, from investigating and
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characterizing previously unknown genes, to querying the function of suspected
particular regulatory regions, to unmasking the consistency and disparity of pat-
terns observed across promoters, splice sites, untranslated regions, and protein do-
mains (ENCODE, 2012). Genomes also served as the basis to advance evolutionary
studies, with even a measure as simple as sequence conservation driving substan-
tial progress in the field of phylogenetics and with greater understanding of both
the evolutionary relationships among species and the mechanisms of evolutionary
processes themselves (Nakhleh, Ringe, and Warnow, 2005; Lynch et al., 2007).
Further, creative methods to use genomes across organisms has led to broad in-
sights about genes’ functions, for instance exploiting the observation that genes that
evolve together are more likely to share function1 (Tillier and Charlebois, 2009). In
numerous ways, research in evolution and molecular and cellular biology has ben-
efited enormously from the increasing completeness of genomes across species.
1.2 Genomes to interactomes
While fully sequenced genomes are a critical step towards understanding,
this list of ingredients across organisms is an oversimplification analogous to early
models of cells as bags of proteins and other chemicals. The field has long un-
derstood that multiple forms of coordination exist at many levels between genes
and cellular organelles, as a significant organizing principle in cells is protein com-
plexes. Research into the molecular mechanisms of cellular behavior in humans
1http://science.sciencemag.org/content/285/5428/751.short
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and other organisms has provided dramatic evidence for the importance of protein
complexes to a vast number of cellular processes (perspectives in Alberts, 1998;
Hartwell et al., 1999). Protein complexes represent a layer of organization that con-
nects individual genes and proteins to their mechanistic cellular functions and to the
phenotypic effects to which they contribute. This modular understanding of molec-
ular biology is key to advance our understanding of the organization of cellular
processes and the link from genotype to phenotype, the evolution and conservation
of biological systems, and how this manifests in human disease.
1.2.1 Incompleteness of protein interactions and complexes
While the relevance of protein complexes in human biology has long been
appreciated, knowledge of protein complexes remains far from complete across
nearly all of biology, including in humans, similar to the state of genomes before
the advent of the first fully-sequenced genomes near 2000 (Adams et al., 2000).
Historically, the discovery of protein complexes has mostly been limited to isolated
studies by various researchers investigating particular cellular processes or diseases
of interest. Even with the incomplete and unreliable state of current knowledge of
protein complexes, studies have already yielded insights into cellular organization,
gene function, and evolutionary mechanisms.
1.2.2 Complexes and functional organization
As early as 2001, the structure of protein interaction networks have been
investigated as a source of information on overall cellular organization. One of the
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early observations of this nature was the observation of a strong correlation between
the degree, or number of interacting partners, of a protein in an interaction network
and its essentiality to cell survival (Jeong et al., 2001). As an organizing feature in
biological systems linking multiple genes to their specific activities and functions,
proteins participating in a complex together tend to share functions. Multiple stud-
ies in yeast revealed that protein complexes share characteristics such as knockout
phenotypes and essentiality (Gavin et al., 2006; G Traver Hart, Lee, and Edward
M Marcotte, 2007). This sharing of function can be applied in reverse to assign
function to genes whose function is unknown or poorly annotated. This principle of
guilt-by-association, which in this context infers function based on the fact that two
interacting proteins are more likely to share function than non-interacting proteins,
has been applied for over a decade and has continued to provide novel biological
insights (Oliver, 2000; Wang and Edward M Marcotte, 2010). Recently, researchers
mapped protein complexes in the bacteria E. coli and used guilt-by-association to
propose functions for nearly one-third of its genome whose functions were at the
time undocumented (Hu et al., 2009). The study of protein complexes also has
a history in improving our understanding of human diseases. Relying again on
the principle of guilt-by-association, researchers used inferred human protein com-
plexes and existing disease-associated genes in a machine learning framework to
predict thousands of additional links between genes and diseases (Lage et al., 2007).
Other groups have employed similar strategies using existing protein-protein inter-
action datasets (e.g., Fraser and Plotkin, 2007). Still others have utilized protein
complexes as a resource to biologists performing high-throughput functional inter-
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action studies as a means to interpret results and provide additional statistical power
to identify weak signals (Vinayagam et al., 2013).
1.2.3 Complexes and evolution
Protein complexes can also reveal novel relationships between genes and
pathways across evolution. As soon as substantial numbers of protein interactions
started to accumulate in yeast and some commonly-studied bacteria, computational
work exploited these interactomes to infer conserved pathways across these dis-
tant species (Kelley et al., 2003). This approach was extended to interactomes
of flies and worms, as significant numbers of interactions were identified in those
species (Sharan et al., 2005). Later, independent groups used alignment of protein
interactions across evolution to infer functional orthologs—genes serving the same
function across species—in cases where sequence-based methods had not yet iden-
tified these genes as orthologs (S Bandyopadhyay, 2006; Singh, Xu, and Berger,
2008). Similar to the discoveries uncovered with the advent of full genomes, more
complete maps of protein complexes spanning evolution will stimulate many new
organizing principles.
1.3 History of mapping protein interactions
Convinced of their value as a lens to understand biological structure and
function, scientists have for decades sought to identify protein-protein interactions
and complexes, as well as develop new experimental techniques and computational
tools to aid them in their search. Early knowledge of protein complexes emerged
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slowly through low-throughput experimental studies isolated to single complexes,
mainly employing biochemical separation methods, such as gel filtration, affinity
chromatography and affinity electrophoresis, to validate prior hypotheses rather
than in an exploratory fashion (Beeckmans, 1999).
1.3.1 Yeast two-hybrid
Beginning two decades ago, groups began using a systematic approach called
yeast two-hybrid (Y2H) to screen for direct physical binding between two proteins
by attaching one protein called the “bait” to the DNA-binding domain of a tran-
scription factor for a marker gene, and the other protein known as the “prey” to the
activation domain of the same transcription factor, thus activating transcription of
the marker gene only when the two proteins bind one another (S Fields and Song,
1989; Brent and Ptashne, 1989). Two groups applied this approach to a subset of
several thousand proteins of the human proteome (Stelzl et al., 2005; Rual et al.,
2005). Another group applied this approach to query pairwise interactions between
approximately 14,000 human proteins (Rolland et al., 2014). Compared to other
approaches, Y2H experiments have the advantage of being highly unbiased in the
interactions they investigate, have equivalent effectiveness regardless of a protein’s
native expression level, and are immune to difficulties other approaches have in
identifying interactions involving membrane-bound proteins (Typas and Sourjik,
2015). Use of Y2H experiments to map protein complexes, however, suffers from
several challenges. First, as only direct binary physical interactions are measured,
complexes themselves are never isolated. Isolating them from binary interactions is
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not straightforward, so they are often not attempted despite the proteome-wide scale
of interactions measured (Rolland et al., 2014). Second, Y2H experiments are not
specific to the native environment and the context in which the interaction usually
occurs, including non-physiological expression levels and a complete lack of the
cellular environment, and thus increasing the potential to capture a large number
of false positivesproteins who stick together in a Y2H experiment but would never
interact physiologically due to different expression levels, timing, tissue specificity,
or subcellular localization of proteins. Third, such experiments require expressing
hybrid versions of the proteins of interest, which raises the question of whether the
proteins are altered in a way that affects their native interaction tendencies.
Beyond the above obstacles to using Y2H experiments specifically to iden-
tify protein complexes, Y2H experiments may also fail to replicate. Post-publication
analysis of published putative protein-protein interactions identified in the same or-
ganism by different labs using Y2H revealed surprisingly low overlap (Von Mering
et al., 2002; Güldener et al., 2006). Recent efforts now include multiple rounds of
screens and multiple stages of validation of observed interactions, which may re-
duce their false-positive rate, though at the cost of increasing experimental efforts
(Rolland et al., 2014). Leaders in Y2H screening remain optimistic that the method
will yield a fully mapped human interactome (Vidal and Stanley Fields, 2014).
1.3.2 Pull-down and mass spectrometry
Several other groups have undertaken a different approach to overcome
these challenges inherent with Y2H screening using pull-down experiments em-
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ploying an affinity purification step followed by mass spectrometry (AP-MS), which
was first successfully performed at a broad scale in yeast (Gavin et al., 2006; Kro-
gan et al., 2006). In this approach, a tagged version of the protein is pulled from
solution along with any other stably bound proteins, and then this mixture is iso-
lated and the other bound proteins in the putative complex identified using mass
spectrometry (Figure 1.1). While overcoming many of the obstacles presented by
Figure 1.1: Affinity purification coupled to mass spectrometry (AP-MS). This
powerful method of identifying co-complex interactions requires tagging or acquir-
ing and validating antibodies for each gene of interest.
Y2H in mapping complexes, AP-MS, is labor-intensive by requiring expression of
a tagged version of the protein, and again fails to observe protein interactions in
its fully-native state. Despite these difficulties, the approach’s success in yeast has
encouraged multiple groups to apply it to mapping complexes in targeted subsets
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of the proteome in a few species including fly and human (Guruharsha et al., 2011;
Malovannaya et al., 2011). Coincident with this work, several groups have pub-
lished larger attempts at mapping human protein complexes through AP-MS, per-
forming pulldowns of between one and three thousand bait proteins and identifying
thousands of co-complex interactions (Hein et al., 2015; Huttlin, Lily Ting, et al.,
2015). One common feature of these studies is the massive scale and complexity,
requiring expression of thousands of tagged proteins, and running and analyzing
thousands of mass spectrometry experiments.
1.3.3 In silico prediction methods
In response to the immense effort, expense and complexity involved in exist-
ing experimental methods to identify protein interactions, a number of groups have
taken in silico approaches to predicting interactions based on other biological data.
Since 2003, one group integrated the limited existing co-complex interaction data,
Y2H data, and other biological data indicative of interactions at the time in a ma-
chine learning framework to predict pairs of proteins likely to be contained within
the same complex in yeast (Jansen et al., 2003). Similarly, an approach taken several
years later drew upon both genetic interactions and AP-MS data in yeast to increase
confidence and coverage beyond either dataset alone to identify protein complexes
(Sourav Bandyopadhyay et al., 2008). Although coverage of their predicted inter-
actions was highly limited by the paucity of reliable input data at the time, their
work showed the power of machine learning and promise of incorporating various
sources of biological data in conjunction with signal-rich experimental data, a prin-
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ciple I have sought to leverage in my own work. More recently, one group achieved
high coverage in predicting yeast co-complex interactions, this time structurally,
by making use of the reasonable coverage of known protein structures in yeast and
extending these through homology modeling (Zhang et al., 2012).
1.3.4 Co-fractionation for massively parallel native protein complex discov-
ery
Lacking the approaches described above as a means to identify protein com-
plexes in their native cellular milieu, unbiased and at high coverage across species
with limited structural knowledge of proteins and without the effort and concerns
involved in tagging thousands of proteins or developing antibodies, we developed
a novel approach to discover native protein complexes. The collaboration between
the Marcotte and Emili labs recently led to the development of co-fractionation
as a method for scalable discovery of native protein complexes. A pilot project,
published while this work was underway, involved approximately a dozen fraction-
ations of two human cell lines and revealed a significant number of human protein
complexes (Havugimana et al., 2012). By developing approaches to incorporate
data and target predictions from multiple species at a much larger scale, the work
described in the following chapters identifies and explores novel interactions and
complexes.
The critical computational infrastructure, tools and analysis that underlie
this undertaking are the subject of this work, as detailed and described in the fol-
lowing chapters. Chapter 2 describes the proteomics data processing infrastructure
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I built to support automated processing of raw data from thousands of mass spec-
trometry experiments using open source tools and search databases, running on
a university-owned cluster infrastructure. Chapter 3 explores the methods I de-
signed to identify co-complex protein interactions from fractionation experiments.
In Chapter 4, I discuss the methods I developed to cluster protein interactions to
produce a large and accurate map of conserved animal protein complexes. In Chap-




An automated pipeline for consistent proteomics data
processing across multiple species
This first major component of my work involved the development of a com-
putational processing pipeline sufficient to derive protein abundances from mass
spectrometry data on a nearly unprecedented scale. Biological sample preparation
and mass spectrometry were led by Cuihong Wan at the University of Toronto.
Additional sample preparation and mass spectrometry was carried out by Ophelia
Papuolas in the Marcotte lab, with assistance from Dan Boutz, and raw mass spec-
trometry data from prior human cell samples was contributed by Pierre Havugi-
mana. The research, development and analysis described in this chapter are my
own work. While this chapter is original and not based on published work, portions
of this work were described in a publication1 by my collaborators in the Emili lab,
on which I was a co-author.
1Wan, C. et al., 2012. ComplexQuant: High-throughput computational pipeline for the global
quantitative analysis of endogenous soluble protein complexes using high resolution protein HPLC
and precision label-free LC/MS/MS. Journal of Proteomics, pp.110. All work described in this
chapter is my own.
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2.1 Background
2.1.1 Mass spectrometry for protein identification and quantitation
Proteomics experiments are now feasible at a scale orders of magnitude
beyond what was possible only a decade ago similar to the present situation in
genomic research. The development of 2-D gel electrophoresis (O’Farrell, 1975)
stimulated interest in the precise measurement of the state of the entire proteome.
Tandem mass spectrometry was effectively applied to protein mixtures a decade
later (Hunt et al., 1986), followed by the addition of liquid chromatography for
greater sensitivity and a database lookup algorithm (Eng, McCormack, and Yates,
1994) to enable identification of hundreds of known proteins in a single run in the
next decade (Link et al., 1999). These developments led to the general mass spec-
trometry experimental and data analysis workflow for proteomics still widely used
today. Protein fragments known as precursor ions enter into the machine, generally
through a liquid chromatography step to separate the mixture for higher sensitivity,
for analysis and produce “MS1” mass per unit charge spectra. Selected precursor
ions are moved into a gas collision chamber and then are broken into smaller pep-
tide fragments, which are passed to a second analyzer producing “MS2” spectra. A
proteome sequence database for the species under study is prepared and subjected
to in-silico digestion and fragmentation according to process models. Spectra mea-
sured experimentally are compared against those computed from the database and
yield scored peptide-spectral matches, which are filtered and aggregated according
to the desired quality control protocols to produce the final protein identification
and quantitation.
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2.1.2 Processing mass spectrometry data
Since that time, the field has seen experiments of increasing scale and com-
mensurately improved coverage of the genome, in terms the number of identified
and quantified proteins. Recent efforts to map the human proteome by leading
proteomics labs, coincident with our own work, have approached the scale of this
project (Kim et al., 2014; Wilhelm et al., 2014). However, as of 2013, even the
largest-scale attempt at capturing the human proteome only analyzed 127 exper-
imental LC/MS-MS runs and identified around 400,000 peptide-spectral matches
(Beck et al., 2011). These experiments are typically analyzed by dedicated pro-
teomics experts in leading laboratories using one or a few high-powered worksta-
tions. Therefore, we developed an alternative approach that would shepherd our
6,387 LC/MS-MS runs through workstations and acquire more than 10,000,000 fil-
tered peptide-spectral matches.
2.2 Approach
2.2.1 A proteomics project of massive scale and complexity
Proprietary data formats are standard for output from modern mass spec-
trometry machines requiring libraries and/or licenses installed on the computers
used to process these raw files into protein quantitations. Microsoft Windows-based
libraries are widely used for this aspect of the workflow, in particular using the pop-
ular software MaxQuant for protein quantitation (Cox and Mann, 2008). However,
our team had several project requirements that made the standard workflow less
feasible.
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First, the sheer quantity of data acquired by our mass spectrometry experi-
ments dwarfs the scale of data in our human-only pilot, as described further in Sec-
tion 2.3, below. The size of our experimental multi-species dataset is rivaled only
by a handful of contemporaneous proteome and interactome surveys, employing
multiple sample conditions and multiple biochemical fractionation steps in order to
achieve greater sensitivity to identify rarer proteins (Hein et al., 2015; Huttlin, Lily
Ting, et al., 2015). Second, we wanted to capitalize on the multiple leading mass
spectrometry database search platforms and leverage MSblender to probabilisti-
cally combine these search results for improved coverage and accuracy (Kwon et
al., 2011). Our lab in collaboration with others previously showed that probabilis-
tic integration of results from multiple search databases improves the sensitivity
and accuracy of proteomic analyses. Given our goal to maximize coverage and
quality across multiple species, we wanted to take advantage of this improvement.
Finally, proteomics projects spanning multiple species are rare, and nothing at this
scale had been attempted to date. An important boost to more effectively compare
and integrate data across species is consistent protocols, both experimentally and
computationally. Since protein sequence database preparation to quality control
and processing choices are central to the aim of this project, consistent handling,
protocols, and treatment across species was required.
2.2.2 Running on open source computational infrastructure
While leading labs that perform such proteome survey experiments often
employ computational proteomics experts dedicated to develop their own protein
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quantitation software and execution of processing on clusters of dedicated full-
access Windows machines, I developed instead an approach to process thousands
of raw mass spectrometry files in an automated manner using our existing available
computational resources. The University of Texas has a large linux-based comput-
ing resources at its disposal in TACC2. So, I developed an automated processing
pipeline that solely relied on open-source components. The resulting pipeline en-
abled conversion, processing, and scoring using thousands of cores in parallel on
TACC (Figure 2.1).
2.2.3 Preparing protein sequence databases
Protein sequence database preparation was a high priority and essential to
enable me to compare and integrate proteomics data across species. One deci-
sion with surprisingly large downstream effects on ease and efficiency for cross-
species comparison was stipulating gene and protein identifiers and protein se-
quence sources. Since ENSEMBL has a gene-focused perspective on identifiers
more conducive to cleaner orthology mappings and covers a significant portion of
our species under study, I chose to rely on protein sequences and identifiers from
ENSEMBL for the available five species and acquired other protein sequences and
gene and protein identifiers of interest from relevant organism-specific databases
(see Section 2.5).
To improve the coverage and quality of identified complexes and to sup-
port the discovery of interactions using co-fractionation experiments across many
2https://www.tacc.utexas.edu/
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LC/MS-MS raw data from 6,387 runs
Broadly-compatible mzXML data
Unfinnigan: raw -> mzML
MSConvert: mzML -> mzXML
MS-GFDBTide InsPecT
MSblender
Automated raw file format conversion
Acquire proteomes for 9 species
MS2 spectral counts
Remove non-canonical regions;  
retain only longest sequence per gene; 
process to consistent formats
Consistent .fasta databases
Retain only spectra 
mapping to unique proteins
PepQuant
Retain only proteins with spectra 




Compute 3 protein profile similarity scores: 
1. Noise-smoothened Pearson correlation 
2. Weighted cross-correlation 
3. Co-apex
Compute protein profile similarity: 
1. Euclidean profile distance
Automated MS2 protein quantitation 
and profile similarity score computation
Automated ms1 protein quantitation 
and profile similarity score computation







Figure 2.1: Automation pipeline for processing data. Top left: Proteome
databases were acquired and processed to produce consistent databases across all
nine species. Top right: LC/MS-MS data was acquired mostly by collaborators,
organized and converted as described in the methods into a format compatible with
open source proteomics tools. Databases and mzXML files were processed to pro-
duce ms1 and ms2 protein quantitations separately, and four similarity scores were
computed for each fractionation from protein quantitations. Intermediate data is
shaded and marked with dotted outlines; existing tools are unshaded boxes. Data
marked as “Deposited” is available via PRIDE/ProteomeXchange, and data marked
as “Website” is available on the project website. For further details on all these
items, see Section 3.5.
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species, sequence databases were processed in several ways. While the assignment
of an identified peptide to multiple proteins has little detrimental effect for the pur-
poses of most proteomics surveys, we found that such multiple assignments can be
problematic to determining interactions and inferring complexes. Thus, I retained
only the longest protein sequence associated with each ENSEMBL gene ID to re-
duce potential spurious predicted interactions between protein isoforms given their
limited unique sequence information and possible biochemical similarity and to also
support cleaner orthology mappings across many species. In addition, sequences as-
sociated with mutant and condition-specific chromosomal locations were removed
for a similar rationale. Finally, I employed the standard method of constructing
combined target-decoy databases through reversal of target protein sequences to
quantify false discovery rates for peptide-spectral matches (Elias and Gygi, 2007).
2.2.4 Integrating multiple database searches
As discussed above, I exploited the added coverage and recall provided by
probabilistically combining results from multiple sequence database search engines
using MSblender (Kwon et al., 2011). We searched our mzXML mass spectrometry
data files against our known protein databases using three established search en-
gines using different identification and confidence assignment methodologies, Tide
(Diament and Noble, 2011), MSGFDB3, and InsPecT4, selecting peptide-spectral




peptide and protein identifications reduced spurious associations between proteins
with high sequence similarity. For example, in the case of close homologs, only
peptides mapping to unique proteins were retained. While this significantly reduced
the overall number of identified peptide-spectral matches, the remaining matches,
still numbering more than 10 million peptide spectral matches across all experi-
ments, were sufficient to provide high coverage across the proteomes of the various
species. This additional filtering of matches dramatically reduced the occurrence
of inferred associations between close homologs, which were likely spurious. See
Section 2.5 for a further discussion.
2.2.5 Automation infrastructure
In order to execute the above process using the massive computational re-
sources available at TACC, I developed a set of bash scripts, python scripts, and
configuration files, with the full source code available for automated MS2 quan-
tification on the web5. Together, these scripts integrate database preparation, file
organization, database searching using three search engines, integration probabilis-
tic peptide identification with MSblender, protein identification, and protein profile
similarity computation (described in Chapter 3) as illustrated (Figure 2.1). Scripts
for integrating with TACC’s interface for parallel computation are also included to
enable execution using hundreds or thousands of cores in parallel.
5https://github.com/marcottelab/blendomatic
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2.2.6 MS1 for additional quantitation information
While MS2 quantitation is fast and widely used for proteome quantitation,
there is some debate as to whether MS1 provides more reliable quantitation, al-
though it may be the case that MS1 at the very least provides additional useful
information (Krey et al., 2014). Thus, for the five species used to derive the con-
served co-complex interactions, I further quantified MS1 precursor ion intensities
as a means to improve quantification accuracy using PepQuant (Wan, Liu, et al.,
2013). Initial results from PepQuant MS1 protein quantitation suggested high
levels of false positive protein identifications compared to both MSblender MS2-
based and MaxQuant MS1- and MS2-based (“iBAQ”) quantitations (Figure 2.2),
but MS1-based quantitation levels from PepQuant could provide useful additional
data. Thus, we reduced false positive identifications in PepQuant by retaining only
those proteins previously identified in a given sample using the MS2 spectra results
derived from MSblender.
2.3 Results
In order to execute the above process using the massive computational re-
sources available at TACC, I developed a set of bash scripts, python scripts, and
configuration files, with the full source code available for automated MS2 quan-
tification on the web6. Together, these scripts integrate database preparation, file
organization, database searching using three search engines, probabilistic peptide
6https://github.com/marcottelab/blendomatic
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Figure 2.2: Consistency between MSblender, PepQuant and MaxQuant. MS1-
based protein profile correlations acquired using PepQuant were compared against
correlations derived using MSblender with MS2 only (our automated approach)
and MaxQuant with MS1 and MS2 (a leading Windows-based software package
for quantitation). While reasonably high consistency was observed between MS-
blender and MaxQuant results (top-left), lower consistency was observed between
PepQuant and both MSblender and MaxQuant (top-right and bottom-right, respec-
tively). Each point in a given scatter plot corresponds to a single protein’s similar-
ity score derived from the indicated quantitation method. For consistency, noise-
smoothened Pearson correlation scores were used in all cases.
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identification with MSblender, protein identification, and protein profile similarity
computation – described further in Chapter 3—as illustrated (Figure 2.1). Scripts
for integrating with TACC’s interface for parallel computation are also included to
enable execution using hundreds or thousands of cores in parallel.
I successfully applied this automated pipeline to our multi-species mass
spectrometry data, extracting more than 10,000,000 peptide spectral matches across
all experiments, corresponding to quantitations for more than 13,000 human pro-
teins and their orthologs from 6,387 mass spectrometry experiments spanning 69
fractionations across nine species (Figure 2.3).
2.4 Discussion
Given the power of proteomics experiments to the extract the state of bi-
ological samples at the protein level, yielding an output much closer than mRNA
expression patterns and with increased physiological relevance, it is not surprising
that such experiments have increased dramatically in both frequency and size in the
past decade. What is surprising to many is the lack of open source and scalable
software tools to support such research. While the publically available pipeline de-
scribed here is far from fulling addressing this need, it takes a significant step in that
direction and points the way forward for future proteomics experts and software de-
velopers to build and share tools that ease the computational burden on proteomic
research labs.
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Figure 2.3: Scale of data. Expanded coverage via experimental scale-up relative
to our prior human-only co-fractionation study (Havugimana et al., 2012). Chart
shows number of proteins detected, most (63%) in two or more species. Adapted
from (Wan, Borgeson, et al., 2015).
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2.5 Methods
Protein databases were obtained from ENSEMBL when available (H. sapi-
ens, M. musculus, C. elegans, D. melanogaster, all downloaded 2012-02-10, re-
lease 65; S. cerevisiae, downloaded 2012-09-03, release 68) and otherwise from
species-specific databases (S. purpuratus: spbase.org 2012-09-03, D. discoideum:
dictybase.org 2012-02-10, N. vectensis: genome.jgi-psf.org 2013-02-19). Because
gene models for X. laevis were not yet finalized, we employed interim gene mod-
els for the analysis using the released transcriptome-derived gene models (Mayball
version) provided by the International Xenopus laevis genome project at the project
website7.
2.6 Open science
As the acquisition and processing of such a large set of proteomics exper-
iments is a highly valuable and much needed resource to the scientific commu-
nity, we made the data publicly available. Our extremely large set of supporting
raw biochemical fractionation mass spectrometry data, including protein sequence
databases and peptide-spectral match scores, totalling over 2TB, were deposited
at ProteomeXchange. Nine datasets, each corresponding to a single species, are
available using identifiers PXD002319 through PXD002328, sequentially.






Machine learning to identify conserved
co-fractionation interactions
This chapter describes my use of machine learning to identify co-complex
interactions using protein abundance data from fractionation experiments. Cuihong
Wan and Sadhna Phanse together performed analysis describing the proportion of
interactions across species, expression pattern similarity of interacting proteins, and
projection of interactions across many species. Kevin Drew led analysis of the spa-
tial relationship between interacting proteins, and collaborated with me to illustrate
the ability of fractionation data to reveal complex substructure. The machine learn-
ing pipeline, the collection and integration of external data, and all other computa-
tional work involved in identifying the core conserved interactions described here
were my own work, along with analyses describing the accuracy of identified inter-
actions, contributions of features, and validation of interactions using held-out test
species. Portions of the text and figures of this chapter are adapted from a paper
published in Nature, where I was joint first author with Cuihong Wan1. I coordi-
1Wan C, Borgeson B, Phanse S, Tu F, Drew K, Clark G, Xiong X, Kagan O, Kwan J, Bezgi-
nov A, Chessman K, Pal S, Cromar G, Papoulas O, Ni Z, Boutz DR, Stoilova S, Havugimana PC,
Guo X, Malty RH, Sarov M, Greenblatt J, Babu M, Derry WB, Tillier ER, Wallingford JB, Parkin-
son J, Marcotte EM, Emili A, Panorama of ancient metazoan macromolecular complexes. Nature,
525(7569):339-44(2015). See text above for my contributions.
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nated the computational efforts, and Cuihong coordinated experimental efforts in
the Emili lab.
3.1 Background
The development of co-fractionation brought a huge increase in efficiency
to identifying thousands of co-complex protein-protein interactions in human cell
lines (Havugimana et al., 2012). This advance stimulated a massive proteomics ef-
fort to dramatically improve the quality and coverage of co-complex interactions
conserved across evolution. Previous cross-species interactome comparisons show
limited overlap (Gandhi et al., 2006; Von Mering et al., 2002) due to relying on
experimental data from different sources and methods. So, we sought to produce a
more comprehensive and accurate map of common protein complexes using a stan-
dardized approach for multiple species. In addition to humans, we selected eight
additional species for study based on their relevance as model organisms spanning
roughly a billion years of evolutionary divergence (Figure 3.1). The Emili and
Marcotte labs together performed more than 50 experiments involving fractiona-
tion followed by mass spectrometry, using multiple tissues and cell types in each of
the nine species and employing several fractionation methodologies and a number
of variants of the affinity bead type (Wan, Borgeson, et al., 2015, Supplementary
Table 1). The resulting co-fractionation data acquired for Caenorhabditis elegans
(worm), Drosophila melanogaster (fly), Mus musculus (mouse), Strongylocentro-
tus purpuratus (sea urchin), and human were used to discover conserved interac-
tions, while the data obtained for Xenopus laevis (frog), Nematostella vectensis
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Figure 3.1: Cross-species deep proteome fractionation. Phylogenetic relation-
ships of organisms analyzed in this study. We fractionated soluble protein com-
plexes from worm (C. elegans) larvae, fly (D. melanogaster) S2 cells, mouse
(M. musculus) embryonic stem cells, sea urchin (S. purpuratus) eggs and human
(HEK293/HeLa) cell lines. Holdout species (‘T’, for test) likewise analysed were
frog (X. laevis), an amphibian; sea anemone (N. vectensis), a cnidarian with primi-
tive eumetazoan tissue organization; slime mold (D. discoideum), an amoeba; and
yeast (S. cerevisiae), a unicellular eukaryote. Adapted from (Wan, Borgeson, et al.,
2015).
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(sea anemone), Dictyostelium discoideum (amoeba) and Saccharomyces cerevisiae
(yeast) were used for independent validation.
Co-fractionation exploits the insight that components of protein complexes
should elute together under varying biochemical fractionation conditions, such that
proteins localized within the same complex should have higher than expected over-
lap in their elution profiles. This is illustrated in cartoon form and with the well-
studied exocyst complex as an example in Figure 3.2.
Figure 3.2: Protein fractionation profiles. Proteins occurring within the same
fraction in a fractionation result in correlated fractionation profiles, at left. Apply-
ing multiple types of fractionations to multiple tissues and cell types extracts richer
information on the consistency or context-dependence of particular interactions and
sub-components. Shown at right are protein profiles in heatmap form for a portion
of a representative single fractionation experiment, illustrating the co-elution of the
well-studied exocyst complex in a concentrated set of three fractions near the mid-
dle of the 120 fractions in the experiment shown. Adapted from (Wan, Borgeson,
et al., 2015).
28
The co-elution of this and many other known complexes grouped individ-
ually in this single fractionation illustrates the principle of the technique and also
validates our decision to employ multiple variants of fractionation across multiple
cell types and tissues. Despite the convincing degree of co-elution in such an exper-
iment, a single experiment can result in elution profiles that overlap to such a large
degree that extraction of individual complexes becomes very difficult except for a
small number of cases.
3.2 Approach
In order to discover protein co-complex interactions prospectively from pro-
tein fractionation profiles across multiple species, I adopted a machine learning
framework similar in concept to that employed in our lab’s previous work using only
human data. In this framework, every pair of observed proteins is first scored for
similarity between the proteins’ fractionation profiles in every fractionation exper-
iment and across the entire dataset. Next, protein pairs exceeding a protein profile
similarity threshold are scored for possible co-complex interactions using super-
vised machine learning with a gold standard derived from manually curated protein
complexes.
3.2.1 Exploration of orthology mapping strategies
To determine the largest set of co-complex interactions from data spanning
multiple species that would be of the highest value to the research community,
I evaluated several approaches. The first option was to identify interactions for
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each species, followed by a comparison of these independently-constructed inter-
action maps. This approach has obvious value to provide species-specific maps
to researchers studying various model organisms, above and beyond the goal of
comparing these interaction maps to discover principles of evolution and proteome
organization. However, this approach also brings significant challenges, especially
with the paucity of data for certain species in our captured fractionation experiments
and the scant biological knowledge embedded in previously published datasets and
public databases for certain species. Such species-species disparities, among other
difficulties, makes false negatives a concern for any cross-species comparisons.
Distinguishing the true lack of interaction from failure to observe an existing in-
teraction in a species with a relatively smaller amount of existing data becomes
unreliable and presents a large obstacle to determining clear takeaways from cross-
species comparisons. While I did not pursue this approach as my primary focus, I
later generated species-specific interaction maps for several species, discussed more
in Chapter 5.
Rather than constructing separate species-specific interaction maps, I incor-
porated data across all our chosen species together in the interaction identification
process, specifically focusing our analysis to identify highly-confident interactions
conserved across evolution. The first inclination was a principled approach first to
identify protein orthogroups for all species under investigation and then to identify
conserved interactions between orthogroups. However, this approach was limiting.
In early testing, it became clear that this approach led to a significant collapse in
the number of interacting entities,which lost valuable interaction information. For
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example in humans, we covered a evolutionary distance of more than half a billion
years between the many paralogs grouped together to construct orthogroups (see
Figure 3.1). In addition, identifying interactions at the level of orthogroups intro-
duced additional rigidity into this process. Periodically, I incorporated new species
into our large and growing dataset. With interactions built around orthogroups, this
new data required me to rebuild our orthogroups, which would both incur signif-
icant computational overhead and create a barrier to replicability as new species
were introduced. Data from a new species would create changes to our previously
identified interactions and also fundamentally alter the nodes of the network. While
interactions between orthogroups are appealing, in principle, for studies of evolu-
tionary changes and divergence, this approach precludes interpretation of the nodes
in our network by biologists regardless of chosen species or model organism for
study. Ultimately, this approach limits its utility and thus decreases the scientific
impact of this work.
For the reasons above, I mapped scored fractionation profile similarities for
each input species back to a single reference species for integration and scoring,
selecting human as the reference. This choice meant that my orthology work only
scaled linearly with the number of species by mapping each species to human. It
also meant that as I added species, I could compare changes to our inferred in-
teractions more directly. Finally, this approach had the benefit of presenting our
interactions in the format most widely interpretable, as interactions between human
proteins.
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3.2.2 Mapping protein profile similarity scores to human
Mapping similarities to human required selecting a method for calculating
pairwise orthologies between the other eight species and human. Orthology map-
ping continues to attract research and discussion and is far from a solved problem,
with multiple different algorithms providing different inferred orthologs. Research
groups continue to evaluate the most commonly-used methods to better understand
their robustness against missing data (Dalquen et al., 2013) and their degree of over-
lap among other topics of investigation (Erik L.L. Sonnhammer et al., 2014). I cal-
culated pairwise orthologies between species using InParanoid 4.1 and using default
settings for BLASTP with BLOSUM62 (Remm, Storm, and Erik LL Sonnhammer,
2001). In order to estimate the extent to which alternative orthology assignments
may influence complex discovery, I measured the extent to which OMA-identified
single copy orthologs between humans and worm, fly, and yeast, were likewise
found by InParanoid. 94+% of OMA identifications were also identified by In-
Paranoid, with only modest discordance (3–6% depending on the species) between
the algorithms. This value provides an approximate bound on the extent to which
alternate ortholog calls might affect co-complex discovery.
To integrate the biochemical fractionation data obtained from the other species
for a given human protein pair, I selected the maximum interaction score for each
species between any orthologs detected for the first human protein and any or-
thologs of the second human protein. In order to minimize spurious associations
resulting from the “fanning out” of interaction evidence across paralogs, I required
an observation of at least one correlation score greater than 0.25 in our human
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fractionation experiments in order to allow the inclusion of interaction data from
additional orthologs.
3.2.3 Generation of similarity scores and features
Based on the MS2-based protein spectral counts, I calculated three mea-
sures of protein co-fractionation. For a pair of protein fractionation profiles, I mea-
sured the: (1) Pearson correlation coefficient, with added Poisson noise to reduce
the influence of low-count proteins (“noise-smoothened Pearson correlation”), (2)
weighted cross-correlation, and (3) co-apex score, which calculated Pearson corre-
lation and co-apex scores with Python as described previously (Havugimana et al.,
2012) and employed an existing R implementation for weighted cross-correlation.
I derived a fourth measure of co-fractionation from the MS1-based precursor ion
peptide intensity measurements, which was implemented as 1 minus the Euclidean
distance between a pair of elution profiles and calculated using pdist (SciPy Python
library Oliphant, 2007). For a given protein pair, a separate score was calculated for
each biochemical fractionation experiment, providing four features for each of the
55 fractionations from the input species, or 220 features total, which served as the
biochemical fractionation feature inputs to the machine learning classifier described
below.
3.2.4 Incorporation of external genomic and proteomic evidence
A driving factor behind the power of fractionation to discover interactions
is its ability to identify interactions between any pair of proteins from a single
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set of experiments rather than requiring targeted experiments for each protein, as
is the case for AP-MS. A challenge that occurs with searching a huge space for
possible interactions like this is the increased potential for false positives. To ad-
dress this concern, I included data from other biological datasets likely to predict
co-complex interactions into the machine learning pipeline as additional features.
As in our previous work (Havugimana et al., 2012), an additional 19 lines of evi-
dence were incorporated from HumanNet (Lee et al., 2011), a network of functional
association between human genes derived from high- and low-throughput experi-
mental databases from multiple species. Datasets include protein-protein associa-
tion scores assembled from co-expression, domain co-occurrence, gene neighbor-
hoods, co-inheritance, previously published high-throughput affinity purification
mass spectrometry (AP-MS) and yeast two-hybrid experimental results reported
prior to 2014 for human, worm, fly and yeast. Computationally predicted interac-
tions from co-citation and literature-curated interactions were used in fly, worm, and
in certain cases yeast, but excluded in human to reduce circularity, since the curated
list of human gold standard complexes was derived using only low-throughput tech-
niques described below. In addition to data from HumanNet, interactions observed
in two additional recent high-throughput AP-MS studies in fly (Guruharsha et al.,
2011) and human (Malovannaya et al., 2011) were also incorporated as additional
features for machine learning (see Section 3.5).
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3.2.5 Curation of gold-standard complexes
For supervised learning of protein co-complex interactions, I generated a
gold standard reference set of complexes from a high-confidence set of manu-
ally curated mammalian protein complexes exclusively from low-throughput ex-
periments, maintained in CORUM (Ruepp et al., 2008). I retained only annotated
human complexes and eliminated approximately 10% of complexes based on them
having been identified using lower confidence identification methods (see Supple-
mentary Table 2 of Wan, Borgeson, et al., 2015 for a complete list). Complexes with
more than 50 annotated members were removed to avoid bias. The resulting set of
complexes was split into two sets. The first was used to train protein co-complex
membership predictions and select parameters for clustering (see Chapter 4). The
second set was withheld as an independent test set for the final evaluation of over-
all platform performance. Within each subset, positive interactions were generated
from protein pairs sharing complex memberships, and negatives were generated
from protein pairs contained in that positive set that did not share complex mem-
berships in any CORUM complexes.
3.2.6 Machine learning to predict conserved interactions
The experimentally derived scores and external scores described above were
used as input features to a machine learning classifier. Protein interactions were
filtered before classification to include only protein pairs with direct biochemical
experimental support (exceeding a score threshold of 0.5) observed in at least two
or more animal species.
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Performance of protein co-complex membership prediction using the more
than 240 input features was evaluated using cross-validation employing only the
training/cross-validation split from the gold standard reference complexes. The
classifier was then trained using the entire combined training/cross-validation and
test splits, and each protein pair with correlated separation profiles in fractionations
from at least two species was scored by a machine learning classifier using the
top 100 selected features. I evaluated multiple classifiers, and selected an SVM
classifier with a linear kernel from the SVC library of Scikit-learn (Pedregosa et
al., 2011), as it performed comparably to or better than other kernels and other
classifiers, including ensemble classifiers, such as random forests, to predict co-
complex memberships and generally produce protein interaction scores that led to
better performance at the clustering stage, described in Chapter 4.
3.2.7 Evaluation of feature contributions
In order to better understand the contributions of species and data sources
contributing to our identified interactions, I also utilized the inherent feature im-
portance representation in a random forest classifier to produce the relative scores
depicted in Table 3.1. This table shows the top 30 of the more than 240 total features
that served as input to the pairwise machine learning interaction scoring pipeline.
This ranking illustrates the breadth of species, external data sources, and fractiona-
tion types that proved most valuable in terms of predictive power against our gold
standard manually curated human co-complex interactions. Since several of the
most important features were from external datasets, I examined how sensitive our
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recovery of gold standard interactions was to the lack of the features ranked as most
important from the external fly AP-MS dataset (Guruharsha et al., 2011). The re-
moval of even this most important feature reduced recall at most by a few percent
at any level of precision.
Table 3.1: Features with highest calculated importance in predicting interactions
Score Species E forExternal Details
0.218 Fly E AP-MS
0.186 Human E AP-MS
0.099 Human Hela nuclear; Isoelectric focusing; MS2 co-apex scoring
0.058 Yeast E Co-expression
0.058 Yeast E AP-MS
0.049 Yeast E Literature-curated
0.047 Human Hela nuclear; Heparin; MS2 weighted cross-correlation scoring
0.047 Human Hela cytosolic; Triple-phase isoelectric focusing; MS2 weightedcross-correlation scoring
0.038 Worm Heparin; MS1 euclidean distance scoring
0.038 Human Hela cytosolic; Sucrose gradient; MS2 pearson correlation scoring
0.038 Worm Whole worms; Heparin; MS2 weighted cross-correlation scoring
0.032 Human Hela cytosolic; Isoelectric focusing; MS2 pearson correlation scoring
0.031 Seaurchin Isoelectric focusing; MS2 weighted cross-correlation scoring
0.029 Human Hela nuclear; Sucrose gradient; MS2 weighted cross-correlation scoring
0.029 Fly E Physical interactions
0.026 Human Hela cytosolic; Triple-phase isoelectric focusing; MS2 weightedcross-correlation scoring
0.026 Human Neural stem cells; Heparin; MS2 pearson correlation scoring
0.025 Mouse Embryonic stem cells; Heparin; MS1 euclidean distance scoring
0.024 Yeast E Co-citation
0.023 Human HEK nuclear; Heparin; MS2 pearson correlation scoring
0.023 Worm Whole worms; Affinity separation flow-through; MS2 weightedcross-correlation scoring
0.023 Human HEK; Agilent HPLC; MS2 weighted cross-correlation scoring
0.022 Human Hela nuclear; Triple-phase isoelectric focusing; MS2 weightedcross-correlation scoring
0.021 Worm Heparin; MS1 euclidean distance scoring
0.021 Worm E Co-citation
0.021 Human HEK nuclear; Heparin; MS2 weighted cross-correlation scoring
0.021 Worm Whole worms; Affinity separation; MS1 euclidean distance scoring
0.021 Worm Whole worms; Affinity separation; MS2 pearson correlation scoring
0.021 Human E Phylogenetic co-inheritance
0.02 Worm Whole worms; Affinity separation; MS2 weighted cross-correlation scoring
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3.3 Results
3.3.1 A high-confidence network of co-complex interactions
The machine learning pipeline described above identified and quantified
13,386 protein orthologs across 6,387 fractions obtained from 69 different exper-
iments, an order of magnitude expansion in data coverage relative to the prior
human-only previous study (Havugimana et al., 2012). Individual pair-wise pro-
tein associations were scored based on the fractionation profile similarity measured
in each species. Measurements of overall performance showed high precision with
reasonable recall by the co-fractionation data alone (Figure 3.3), with external data
sets serving only to increase precision and recall, as all derived interactions were
required to have biochemical support. Co-fractionation data of each input species
affected overall performance, in each case increasing precision and recall (Fig-
ure 3.4). The final filtered interaction network consisted of 16,655 high-confidence
co-complex interactions in human, available for download2. All interactions were
supported by direct biochemical evidence in at least two input species, with half
(8,121) detected in three or more (Figure 3.5). This enabled cross-species mod-
elling and functional inference.
3.3.2 Functional and disease enrichment of interacting proteins
Multiple lines of evidence support the quality of the network. Reference
complexes withheld during training were reconstructed with higher precision and
recall (Figure 3.3) relative to the previous human-only map (Havugimana et al.,
2“PPI & Correlations” at http://metazoa.med.utoronto.ca
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Figure 3.3: Relative contributions of fractionation and external data. Per-
formance benchmarks, measuring precision and recall of our method and data in
identifying known co-complex interactions (annotated human complexes from CO-
RUM [Ruepp et al. 2008]). Complexes were split into training and withheld test
sets; five-fold cross-validation against 4,528 interactions derived from the withheld
test set shows strong performance gains, beyond baselines achieved using only co-
fractionation or external evidence alone. TP, true positive; FP, false positive; FN,
false negative. Adapted from (Wan, Borgeson, et al., 2015).
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Figure 3.4: Contributions of data from additional species. Performance bench-
marks, measuring the precision and recall of our method and data in identifying
known co-complex interactions from a withheld reference set of annotated hu-
man complexes (from CORUM [Ruepp et al. 2008]; as in Figure 3.3). Five-fold
cross-validation against this withheld set shows strong performance gains, beyond
a baseline achieved using only human and mouse co-fractionation data along with
additional evidence from independent protein interaction screens (Guruharsha et
al., 2011; Malovannaya et al., 2011) and a functional gene network (Lee et al.,
2011) (far-left curve), made by integrating co-fractionation data from the additional
non-human animal species (as indicated). “All data” and “Fractionation data only”
curves include biochemical fractionation data from all five input species: human,
mouse, urchin, fly and worm; the latter curve omits all external data. In all cases, at
least two species were required to show supporting biochemical evidence. Recall
refers to the fraction of 4,528 total positive interactions derived from the withheld
human CORUM complexes. Adapted from (Wan, Borgeson, et al., 2015).
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Figure 3.5: Proportion of PPI across species. All 16,655 interactions were iden-
tified at least in two species, half (49%, 8,121) found in three or more species.
Adapted from (Wan, Borgeson, et al., 2015).
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2012). The interacting proteins were also enriched sixfold (hypergeometric P <
1 × 10−24) for shared subcellular localization annotations in the Human Protein
Atlas Database (Uhlén, Oksvold, et al., 2010), 21-fold enriched (P < 1 × 10−56)
for shared disease associations in OMIM22 and were highly correlated with human
tissue proteome abundance profiles (Kim et al., 2014) (Figure 3.6).
Figure 3.6: Expression pattern similarity of interacting proteins. Distribution of
global protein tissue expression pattern similarity, measured as the Pearson corre-
lation coefficient of protein abundance across 30 human tissues (Kim et al., 2014),
showing markedly higher correlations for 16,468 pairs of putative co-complex in-
teraction partners compared to the same number of randomized pairs of proteins in
the network which were not predicted to interact. Adapted from (Wan, Borgeson,
et al., 2015).
3.3.3 Inferred structural relationships through hierarchical protein profile
similarities
Besides indicating stably associated proteins, our multispecies biochemical
profiles faithfully recapitulated the architecture of multiprotein complexes of known
three-dimensional structure, with a general trend for most correlated protein pairs
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to be spatially closer (Figure 3.7). For example, hierarchical clustering of 30S
Figure 3.7: Highly correlated proteins are spatially closer. The degree of co-
fractionation is measured as the correlation coefficient between elution profiles.
Spatial proximity is calculated from the mean of residue pair distances between
components of multisubunit complexes with known three-dimensional structures.
Adapted from (Wan, Borgeson, et al., 2015).
proteasome subunits according to chromatographic elution profiles of all five input
species correctly separated the 20S and 19S particles and the regulatory lid from the
base sub-complex (Figure 3.8), reflecting known hierarchies of complex formation
and disassembly.
3.3.4 Verification of the conserved nature of identified interactions
To independently verify the reliability of these projections, I examined the
co-fractionation profiles of putatively interacting orthologs (interologs) in the four
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Figure 3.8: Hierarchical clustering reveals proteasome substructure. Left, rep-
resentative co-fractionation data (normalized spectral counts shown for portions of
3 of 42 experimental profiles) from human, fly and sea urchin showing characteris-
tic profiles of proteasome core, base and lid sub-complexes. Hierarchical clustering
(right) of pan-species pairwise Pearson correlation scores (centre) is consistent with
accepted structural models (Protein Data Bank ID: 4CR2; core, red; base, blue; lid,
green; out-clusters, white). Adapted from (Wan, Borgeson, et al., 2015).
44
holdout species, as obtained by protein quantification across 1,127 biochemical
fractions (see Section 3.5). Most of the predicted interactors showed highly cor-
related co-fractionation profiles among the holdout test species to a degree compa-
rable to those of the input species used for learning (Figure 3.9). The biochemical
Figure 3.9: Conservation of interactions in independent species. Plots showing
high enrichment (probability ratio of interacting) of predicted interacting ortholo-
gous protein pairs (relative to non-interacting pairs) among highly correlated frac-
tionation profiles, in both the holdout validation (test, T) and input species (colours
reflect clade memberships). Adapted from (Wan, Borgeson, et al., 2015).
data obtained for sea urchin and sea anemone showed slightly better agreement than
that for Dictyostelium and yeast, which was proportional to evolutionary distance
(Rubin et al., 2000).
3.3.5 Prediction of conserved interactions across species
Because most interacting components were phylogenetically conserved across
vast evolutionary timescales, our conserved interactions were further used to predict
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over one million high-confidence co-complex interactions among orthologous pro-
tein pairs for 122 extant eukaryotes with sequenced genomes, available for down-
load3. The number of interactions ranged from ~8,000 to ~15,000 per species de-
pending on the phyla (Figure 3.10), with more projected among deuterostomes,
Figure 3.10: Projection of conserved co-complex interactions across 122
species. Projection of conserved co-complex interactions across 122 eukaryotic
species, indicating overlap with leading public PPI reference databases. STRING
bars indicate excess over CORUM; GeneMANIA bars indicate excess over both;
component and interaction occurrences across clades indicated at bottom. Adapted
from (Wan, Borgeson, et al., 2015).
protostomes and cnidaria, and showing high component retention. Fewer were pro-
jected in fungi, plants and, especially, protists, where the relative paucity of co-
complex conservation probably reflects inherent clade diversity, especially in para-
site genomes (for example, gene loss among Apicomplexa). While largely congru-
ent with previous smaller-scale studies of PPI conservation (Bezginov et al., 2013),
the majority of conserved co-complex interactions are novel, as less than one-third
are curated in CORUM, STRING and GeneMANIA databases. This markedly
3“Predicted PPI” at http://metazoa.med.utoronto.ca
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increased the number of metazoan protein interactions reported to date, covering
roughly 10%–25% of the estimated conserved animal cell interactome (Stumpf et
al., 2008; G. Traver Hart, Ramani, and Edward M. Marcotte, 2006) and promotes
many new avenues of inquiry.
3.4 Discussion
Accurate identification of physiologically relevant protein interactions has
long been a challenging undertaking. Here, using a large number of co-fractionation
experiments using different fractionation methods on different cell types and tissues
from many animal species and incorporating additional evidence of interactions, I
identified and validated more than 13,000 conserved interactions to a level of con-
fidence that allowed their projection across over a hundred species, taking a large
step forward in the number of confident interactions expected across an important
branch of the tree of life. In addition, among member proteins of the same complex,
I identified a hierarchical structure within the fractionation profiles signatures and
determined that they indicated complex subcomponents, proximity and assembly
order. These results together illustrate the value of integrating multiple methods of
biochemical fractionation to support the identification of protein interactions and
interrogation of complex substructure.
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3.5 Methods
3.5.1 Filtering away of peptides matching to multiple proteins
As discussed in Chapter 2, both our protein sequence databases and our
peptide-spectral matches were processed to reduce the occurrence of spurious as-
signment of a single peptide to multiple proteins. In fact, from the onset I used
only the single longest protein sequence per gene. The later decision also removed
peptide-spectral matches that could correspond to multiple distinct genes, an arti-
fact apparent in our investigations of inferred co-complex interactions. These in-
teractions initially contained numerous examples of inferred interactions between
genes that were clearly close homologs–in fact a significant fraction of observed
co-complex interactions fell into this category, which was an unexpected obser-
vation. By removing all peptide-spectral matches corresponding to peptides with
perfect matches against multiple proteins, I observed the near complete removal of
this observed effect. While it is possible that some or even many of these inferred
interactions truly occur in the underlying biology, inferring interactions with high
sensitivity between highly similar proteins using mass spectrometry is a challenge
for additional experimental methods or more nuanced computational approaches to
examine.
3.5.2 Incorporation of external interaction datasets
While the fly data (Guruharsha et al., 2011) was conveniently available in a
format easily interpretable to use in inferring co-complex interactions, human data
(Malovannaya et al., 2011) required additional processing. For each pairwise in-
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teraction indicated by the human dataset, the authors indicated confidence by nam-
ing each inferred complex (“MemoID”) with the first letter A/P/T indicating the
confidence level of accepted, provisional, and tentative, respectively. In surveying
the distribution of these confidence levels and some cross-validation evaluation, I
scored each interaction as 10 for each accepted interaction, 3 for provisional and 1
for tentative.
3.5.3 Validation using co-fractionation of independent taxa
To validate that the 16,655 high-confidence co-complex interactions were
in fact conserved across species and not used to generate the map, I determined
whether and to what degree interacting pairs of proteins in our high confidence
network were more likely than non-interacting pairs of proteins to co-fractionate
together in the four independent test species—the African clawed frog X. laevis,
the starlet sea anemone N. vectensis, the budding yeast S. cerevisiae, and the mul-
ticellular amoeba D. discoideum. For the set of non-interacting proteins, I took
the 3,464 proteins forming our high-confidence interaction network and formed all
possible pairs between them not accounted for in our interaction data, amounting
to 5,981,261 putatively non-interacting pairs. For each of the four independent
species, I calculated the Pearson correlation coefficient with added Poisson noise
to reduce the influence of low-count proteinsthe first of the four co-fractionation
scores described above, and the one with the broadest coverage across pairs. To in-
tegrate biochemical fractionation data for each of the four independent species for
a given human protein pair, the maximum interaction score was taken between any
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orthologs of the first human protein and any orthologs of the second human protein.
These scores were averaged across all fractionations for each species respectively.
For each species, I then tallied the number of interacting and non-interacting pairs
scoring between -1 and -0.5, .-5 and 0, 0 and .5, and .5 and 1, and then calculated a
ratio with the fraction of interacting pairs scoring in that bin as the numerator and
the fraction of non-interacting pairs scoring in that bin as the denominator, analo-
gous to the calculation of relative risk in epidemiological studies.
3.6 Open science
High-confidence conserved interactions in human are available for down-
load4. Python code for the entire machine learning pipeline, including training/test
set creation from the gold standard, cross-validation, and supporting functions to
generate many of the visualizations, is publicly available online5.




Clustering and exploration of protein complexes
This final component of my work describes the development and use of clus-
tering metrics and methods to derive protein complexes from co-fractionation pro-
tein interactions. Experimental validation and functional exploration of the Com-
mander complex were performed by Fan Tu in John Wallingford’s developmental
biology lab. Cuihong Wan and Sadhna Phanse in the Emili lab analyzed evolu-
tionary age and abundance trends among complexes. Kevin Drew led analysis of
molecular weights. The exploration of clustering methods and metrics and develop-
ment of the automated clustering pipeline were my own work, along with genera-
tion of the identified conserved protein complexes and global computational valida-
tion. I analyzed sequential metabolic enzyme complexes as suggestions of possible
metabolic channeling. Portions of the text and figures of this chapter are adapted
from a paper1 published in Nature, on which I was joint first author, coordinat-
ing the computational efforts, with Cuihong Wan, who coordinated the biological
experimental efforts in the Emili lab.
1Wan C, Borgeson B, Phanse S, Tu F, Drew K, Clark G, Xiong X, Kagan O, Kwan J, Bezgi-
nov A, Chessman K, Pal S, Cromar G, Papoulas O, Ni Z, Boutz DR, Stoilova S, Havugimana PC,
Guo X, Malty RH, Sarov M, Greenblatt J, Babu M, Derry WB, Tillier ER, Wallingford JB, Parkin-
son J, Marcotte EM, Emili A, Panorama of ancient metazoan macromolecular complexes. Nature,
525(7569):339-44(2015). See text above for my contributions.
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4.1 Background
Pairwise protein complex co-membership scores from the machine learning
pipeline described above formed a weighted protein interaction network. A useful
way to interpret such networks is through a soft partition into stable assemblies
of multiple proteins into complexes (Alberts, 1998). Low-throughput studies and
manually curated protein interactions often take this approach (Ruepp et al., 2008).
Therefore, I developed a method to cluster our network of highly confident protein
interactions into such a representation that identified dense clusters to reveal protein
complexes.
4.1.1 Clustering graphs
Clustering graphs has been a topic of some research for several decades.
With the advent of high-throughput protein-protein interaction studies, clustering
protein interaction networks has seen increasing research efforts from many groups
over the last 15 years. The Markov Clustering Algorithm (MCL) is particularly
prominent among general purpose graph clustering algorithms still in wide use to
cluster protein interactions. MCL is based on the principles of flow and random
walks, with the simple idea that a random walk visiting a densely connected region
in a graph will not leave that densely connected region as often, indicating a cluster
(van Dongen, 2000). Its continued use is likely due, at least in part, to its broad
applicability, ease of use, easy-to-visualize algorithm and computational efficiency.
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4.1.2 Clustering protein interactions
In the following decade, numerous approaches were developed specifically
with the goal of clustering protein interactions, including MCODE (Bader and
Hogue, 2003) and CFinder (Adamcsek et al., 2006). MCODE introduced a dif-
ferent algorithm along with a number of additional parameters into the clustering
process to permit researchers to hone size, shape, and other aspects of identified
complexes. It also introduced appropriate metrics to evaluate the quality of pro-
tein clusters. Rather than partitioning a graph into subgraphs according to density,
CFinder introduced the idea of overlapping complexes, in which nodes (proteins)
could participate in multiple clusters. This approach necessitates developing dif-
ferent algorithms, but closely aligns with the understanding most biologists hold
regarding complex identification. More recently, a group of collaborators from our
previous human fractionation project (Havugimana et al., 2012) evaluated a host of
protein interaction clustering tools and developed a method, called ClusterONE, to
address their perceived shortcomings in the existing approaches (Nepusz, Yu, and
Paccanaro, 2012). The group developed three new clustering metrics, which they
combined, to represent their best representative estimate of clustering quality. They
found MCL generally produced the best scores across several different protein in-
teraction datasets. They sought to meet or exceed its evaluated performance while
maintaining the ability found in some new algorithms to allow proteins to partici-
pate in multiple complexes. They succeeded in this goal for their chosen metrics,
with ClusterONE producing consistently higher clustering quality than MCL, while
retaining many features introduced by MCODE, and also supporting the assignment
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of proteins to multiple complexes.
4.2 Approach
4.2.1 An automated pipeline for clustering
In our initial attempts to identify protein complexes from our co-fractionation
network of protein interactions, I employed ClusterONE given its advantages dis-
cussed in the introduction. As mentioned, ClusterONE employs several parameters
useful for tuning the properties of identified complexes to drive better performance
depending on the structure and size of the input interaction network. To explore the
range of possible parameter choices, I built an automated pipeline that tested the
output of the clustering process against a training set of complexes derived from
CORUM, our gold standard of manually-curated human complexes (Ruepp et al.,
2008). I also tested MCL, verifying that ClusterONE produced complexes scor-
ing better against the gold standard while allowing protein assignment to multiple
complexes.
4.2.2 Opportunities for clustering improvement
However, while visually inspecting high-scoring clusterings, I found that
the metrics employed previously by the ClusterOne authors did not sufficiently ac-
count for many features of clustering that we found important to the quality of the
output. One particular disregarded aspect of the clustering output was a measure of
redundancy among the identified complexes. If proteins can participate in multiple
complexes, the opportunity exists for certain combinations of clustering parameters
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to result in clusterings that achieve high scores per the ClusterONE developers’ cho-
sen metrics, while exhibiting a high degree of redundancy, for instance, representing
both a 10-unit complex along with several highly similar 8- or 9-unit versions.
A second disadvantage of these initial high-scoring clusterings was a per-
ceived over-collapse of multiple very large complexes. Identifying a true complex
significantly larger than the largest ones known, such as the ribosome, would be
remarkable, but highly surprising. So, I was skeptical when I discovered multiple
such candidate complexes in the early highest-scoring overall clusterings, espe-
cially as investigation into the numerous members left little room for doubt that
multiple complexes, connected by numerous lower-confidence interactions, were
being grouped together. In essence, in a parameter regime performing well on the
high number of small- to medium-sized complexes, ClusterONE performed poorly
on very large complexes in our view. While ClusterONE’s metrics concerning the
quality of the overall clustering were strong, the trade-off in poor quality on a small
number of larger complexes was unsatisfactory. So, I sought to develop a combina-
tion of new metrics and different methods to resolve the issue.
4.2.3 Exploration of clustering quality and metrics
Given the dissatisfaction with the redundancy and over-collapsed nature ob-
served in the tested ClusterONE results, I explored numerous additional clustering
metrics suggested in prior work (Bader and Hogue, 2003; Adamcsek et al., 2006), in
addition to developing several new metrics. These metrics were developed primar-
ily to evaluate a proposed clustering of protein interactions against the training split
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of gold standard complexes derived from CORUM. I also devised several metrics
simply to measure aspects of the clustering itself, such as the level of redundancy.
Initial attempts to improve overall clustering quality involved using various com-
binations of selected metrics to choose some proposed clusterings. Each had the
highest combined score along some particular combination of metrics when com-
pared to the training set of gold standard complexes. Their performance on each of
the 15 metrics is illustrated in Figure 4.1.
Optimizing against such a large number of clustering metrics and under-
standing the various trade-offs to balance metrics against one another proved chal-
lenging, so progress toward an enhanced clustering was elusive. In my attempts
to manage these trade-offs, I noticed that a number of the metrics fluctuated to-
gether, which implied that the correlation structure among many metrics could pro-
vide a useful simplification of the task at hand. Surprisingly, a simple hierarchical
clustering of the metrics based on pairwise correlations of their values across a
few thousand clusterings from my automated parameter exploration revealed that
the clustering metrics fell into essentially two groups—one group correlating with
higher recall and another group correlating with higher precision (Figure 4.2). The
strong correlation structure enabled me to pare down to just three crucial metrics.
From this point onward, I evaluated clustering performance using only three
measures: the average non-overlap, maximum matching ratio, and sensitivity. The
average non-overlap was calculated by averaging the number of clusters in the map
over a range of thresholds from 0 to 1, for which another cluster could be iden-
tified yielding a pairwise overlap greater than the given threshold. This average
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Figure 4.1: Optimizing clustering against many metrics. These 15 histograms
correspond to 15 different clustering metrics, named at left. Data comes from over
1,000 clusterings, 900 produced by the automated clustering pipeline (shown in
blue) and 200 produced by random permutations of randomly-chosen clusterings to
preserve overall network topology (shown in red). The blue, green, and black mark-
ers represent 3 different candidate clusterings. The blue clustering is the tightest,
with the highest precision as measured against the gold standard corum complexes,
and has the highest scores on metrics related to precision, like separation (fifth
from the top), and lowest on scores that reflect the overall coverage of the map, like
n proteins (total number of unique proteins, second from the bottom). The green is
medium, and the black is lowest precision and highest coverage.
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Figure 4.2: Redundancy among clustering metrics. Shown is the correlation
between each pair of metrics across thousands of clusterings, green highlighting a
positive correlation, and red negative. The correlations show that the metrics break
down very strongly into two camps: the top/left ones that reflect or are tied mainly to
the size and recall of the clusterings, and the bottom/right ones that approximately
represent the precision/specificity of the clusterings.
value was then subtracted from one to provide a positive, increasing measure of
quality. Next, the maximum matching ratio assigns one-to-one best matches be-
tween complexes in the gold standard and predicted sets. It reports the average
overlap score achieved for gold standard complexes using the same overlap score
as above. Finally, sensitivity scores the precision of the predicted complexes against
the gold standard, both as previously described (Havugimana et al., 2012; Brohée
and Helden, 2006). Empirically, I found that requiring a minimum value of 0.75 for
average non-overlap for a clustering produced maps with a reasonably low level of
redundancy according to myself and colleagues, while still allowing complexes to
overlap enough to be biologically feasible. Within this constraint, clusterings were




While the winnowing of metrics to three and the added constraint involv-
ing the new non-overlap metric simplified clustering evaluation and resolved issues
with redundancy, the over-collapse of large complexes remained a concern. As de-
scribed above, visual inspection of some of the largest complexes suggested that
they were composed of multiple potentially high-quality smaller complexes, bound
together with numerous, but somewhat weak, interactions between them. Attempts
to repair this issue using different parameter choices in ClusterONE met with very
limited success before having a significant negative impact on the overall quality
of the rest of the identified complexes in the clustering. Recalling the effectiveness
of MCL in effectively cutting graphs into smaller subgraphs, I experimented with
a two-stage clustering process. Complexes identified via ClusterONE were imme-
diately processed individually with MCL. By merging MCL and its single tunable
parameter into my clustering parameter exploration pipeline, I produced clusterings
that scored higher on all metrics, while simultaneously resolving the over-collapse
of the largest complexes and retaining a relatively low level of redundancy. See
Section 4.5 for more details on optimal clustering parameters.
4.2.5 Incorporating non-clustered high-scoring interactions
While the two-stage clustering process described above successfully re-
solved concerns with over-collapse and redundancy, one new concern arose re-
garding the robustness of the clustering process to input interactions. I found that
even very slight alterations to the scores of the determined protein interactions often
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caused significant fluctuations in the complexes identified by the clustering process,
in particular the appearance or disappearance of numerous single interactions. To
increase the robustness of the clustering, I included all very highly confident inter-
actions, roughly 500, in the final clustering output, described further in Section 4.5.
4.3 Results
4.3.1 A map of conserved metazoan complexes
The 981 putative multiprotein groupings include both well-known and novel
complexes linked to diverse biological processes (Figure 4.32). The final conserved
metazoan complexes comprise 7,669 high confidence pairwise interactions among
2,153 distinct (human) proteins. The complexes have estimated component ages
spanning from ~500 million (metazoan-specific or “new”) to over one billion years
(ancient or “old”) of evolutionary divergence. Co-complex interactions among the
complexes show an improvement in precision relative to the high-confidence inter-
actions that served as input to the clustering process (Figure 4.4).
4.3.2 Independent biological assessment
We used multiple approaches to assess the accuracy of the predicted com-
plexes. First, my colleagues performed affinity purification mass spectrometry
(AP/MS) experiments on select novel complexes based on their absence from cu-
rated databases BioGrid v3.2.102 (Stark et al., 2006) and IRefWeb v4.1 (Turner
2Available for download under “Complex Network” at http://metazoa.med.
utoronto.ca
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Figure 4.3: 981 conserved animal protein complexes. Schematic of 981 identified
complexes containing 2,153 unique proteins. In this graphical representation, 7,669
co-complex interactions are shown as lines, and proteins as nodes. Red and green
interactions were previously annotated in CORUM. Red interactions were used in
training the classifier and/or clustering procedure, while green interactions were
held out for validation purposes. Grey interactions were not previously annotated
in CORUM. Adapted from (Wan, Borgeson, et al., 2015).
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Figure 4.4: Final precision/recall performance on withheld interaction test set.
A support vector machine classifier was trained using interactions derived from our
training set of CORUM complexes, then, 1 million protein pairs found to co-elute in
at least two of the five input species were scored by the classifier. Black curve shows
precision and recall for ranked list of co-eluting pairs, with recall representing the
fraction recovered of 4,528 total positive interactions derived from the withheld set
of merged human CORUM complexes, and precision measured using co-eluting
pairs where both members of the pair are contained in the set of proteins represented
in the CORUM withheld set. The top 16,655 pairs, giving a cumulative precision
of 67.5% and recall of 23.0% on this withheld test set, form the high- confidence
set of co-complex proteinprotein interactions (blue circle). Adapted from (Wan,
Borgeson, et al., 2015).
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et al., 2010) which indicated that they were not reported in either human, mouse,
worm, fly or yeast. These experiments validated most associations in both worm
and human (see Wan, Borgeson, et al., 2015). Second, I performed a global val-
idation by comparing our derived complexes to a recent large-scale AP/MS study
of 23,756 putative human protein interactions detected in cell culture (Huttlin, Lily
Ting, et al., 2015) along with CORUM curated mouse complexes and CYC2008
(Finn et al., 2014) yeast complexes. In all cases, I observed a partial, but highly sta-
tistically significant, overlap to a degree comparable to literature-derived complexes
(Figure 4.5).
Figure 4.5: Global validation of complexes. Conserved complexes significantly
overlap large-scale AP/MS data reported for human cell lines (Huttlin, L. Ting, et
al., 2016) to a comparable extent as literature reference sets (Ruepp et al., 2008),
using three measures of complex-level agreement (see Section 4.5); ***P , 0.001,
determined by shuffling (grey distributions). Adapted from (Wan, Borgeson, et al.,
2015).
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4.3.3 Evolutionarily conserved complexes and subunits
Although proteins arising in metazoa account for about three quarters of
all human gene products through gene duplication or other means, they form only
39% of the clusters (Figure 4.6, a). These “new” complexes tend to be smaller (#3
components; Figure 4.6, b) and specific to components not present in “mixed” com-
plexes. Even though protein number and diversity greatly increased with the rise
of animals (Bezginov et al., 2013), these “new” complexes suggest that most sta-
ble protein complexes were inherited from a unicellular ancestor and subsequently
modified over time to various extents (Figure 4.6, c). Indeed, the dominant phylo-
genetic profile of complexes across Eukarya (Figure 4.6, d) is composed of ancient
subunits ubiquitous among eukaryotes, either entirely (344 old complexes) or pre-
dominantly (490 mixed complexes), the latter presumably reflecting preferential
accretion of additional components to pre-existing macromolecules (Eisenberg and
Levanon, 2003).
These primordial complexes are present throughout the Opisthokonta super-
group (animals and fungi), estimated to be more than one billion years old (Knoll,
1992), and plants (and presumably lost/significantly diverged among parasitic pro-
tists). Reflecting this central importance, these complexes have strong, ubiquitous
expression, abundant throughout all cell types and tissues (Figure 4.7).
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Figure 4.6: Conservation of protein complexes across Metazoa and beyond. a,
Conserved multiprotein complexes, identified by clustering, arranged according to
average estimated component age (see Bezginov et al., 2013). Proteins (nodes) clas-
sified as metazoan (green) or ancient (orange); assemblies showing divergent phylo-
genetic trajectories termed “mixed”. b, Example complexes with different propor-
tions of old and new subunits. c, Presumed origins of metazoan (new), mixed and
old complexes; “?” indicates variable origins of new genes. d, Heat map showing
prevalence of selected complexes across phyla. Colour reflects fraction of compo-
nents with detectable orthologues (absence, dark blue). Sea anemone (N. vectensis)
is the most distant metazoan (cnidarian) analyzed biochemically. Adapted from
(Wan, Borgeson, et al., 2015).
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Figure 4.7: Abundance and expression trends for proteins in complexes. Pro-
teins within the identified complexes tend to be ubiquitously expressed across hu-
man tissues. Top, pie chart shows the proportions of proteins with varying tissue
expression patterns, from a recently published human tissue proteome map (Uhlén,
Fagerberg, et al., 2015). Consistent with this observations, 91% of the protein com-
ponents in the complexes were expressed in more than 15 tissues in data from a
reference human proteome (Kim et al., 2014), compared to less than half (46%)
of the 17,294 proteins in the overall reference set (Z-test P < 0.001) Bottom,
The distributions of average protein (data from PaxDb integrated data set, 9606-
H.sapiens whole organism-integrated data set) abundances for all proteins identi-
fied and those within complexes. Evolutionarily old proteins (defined by OMA as
described in Bezginov et al., 2013 and mentioned earlier) tend towards higher abun-
dances, even for proteins in reference complexes. Adapted from (Wan, Borgeson,
et al., 2015).
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4.3.4 Experimental validation and functional characterization of a novel con-
served complex
We also observed broad agreement between the derived complexes’ inferred
molecular weights (assuming 1:1 stoichiometries) and migration by size-exclusion
chromatography (Figure 4.8). A prime example is the coherent profiles of a large
Figure 4.8: Agreement of complex size with size-exclusion data. Inferred molec-
ular weights (MW) of human protein complexes tend to agree with size-exclusion
chromatography profiles from Kirkwood and Lamond, 2013. Adapted from (Wan,
Borgeson, et al., 2015).
(~500kDa) mixed complex with several un-annotated components (Figure 4.9),
dubbed “Commander”, because most subunits share COMM (copper metabolism
MURR1) domains (Burstein et al., 2005) implicated in copper toxicosis (van de
Sluis et al., 2002), among other roles (Burstein et al., 2005; McDonald, 2013).
Commander contains coiled-coil domain proteins CCDC22 and CCDC93 in ad-
dition to ten COMM domain proteins, broadly supported by co-fractionation in
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Figure 4.9: Co-fractionation consistency of the Commander complex. Ex-
ample protein elution profiles are plotted for Commander complex subunits ob-
served from: HEK293 cell nuclear extract (a); sea urchin embryonic (5 days post-
fertilization) extract (b); and fly SL2 cell nuclear extract (c); each fractionated by
heparin affinity chromatography. d, Co-elution of human Commander complex sub-
units by size-exclusion chromatography, consistent with an approximately 500-kDa
particle. Adapted from (Wan, Borgeson, et al., 2015).
human, fly and sea urchin3.
We found an unexpected role in embryonic development for Commander,
whose subunits are strongly co-expressed in the developing frog (Figure 4.10).
COMMD2/3-knockdown (morpholino) tadpoles showed impaired head and eye de-
velopment (Figure 4.11) and defective neural patterning and expression changes in
brain markers PAX6, EN2 and KROX20/EGR1 (Figure 4.12). Given the recently
discovered link (Kolanczyk et al., 2015; Voineagu et al., 2012) between CCDC22
and human syndromes that exhibit intellectual disability, malformed cerebellum
and craniofacial abnormalities, the deep conservation of the Commander complex
3See supporting website, http://metazoa.med.utoronto.ca/php/view_
elution_image.php?id=71&cond=ms2
68
Figure 4.10: Developmental co-expression of Commander subunits. Co-
expression of Commander complex subunits during embryonic development of X.
tropicalis (plotting mean plus/minus standard deviation of three clutches; data from
Yanai et al., 2011). Adapted from (Wan, Borgeson, et al., 2015).
Figure 4.11: Impaired eye development in Commander morphants. Morpholino
(MO(ATG), targeting start codon to block translation) knockdown of COMMD2
(n=55 animals, 2 clutches, 1 eye each) or COMMD3 (n=64) in X. laevis embryos
causes defective head and eye development (control n=57). ***P < 0.0001, two-
sided Mann-Whitney test. Adapted from (Wan, Borgeson, et al., 2015).
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Figure 4.12: Altered neural patterning with Commander knockdown.
COMMD2/3 knockdown animals (five embryos per treatment examined) show al-
tered neural patterning, including posterior shift or loss of expression of mid-brain
marker EN2 and KROX20 (EGR1). Adapted from (Wan, Borgeson, et al., 2015).
suggests COMMD2/3 is a strong candidate in the aetiology of these heterogeneous
disorders.
4.3.5 Network perspective into conserved biological systems
Knowledge of conserved macromolecular associations provides a roadmap
for additional functional inferences. For instance, fractionation profiles can be com-
pared for any protein pair in our data set to search for evidence of interactions. I
found a significant enrichment for interactions among pairs of human proteins act-
ing sequentially in annotated pathways (Croft et al., 2014), especially G-protein and
MAP-kinase cascades (Table 4.1). Enzymes acting consecutively in core metabolic
reactions also showed a higher tendency to interact. The significance of these in-
teraction tendencies decayed with more intervening steps. For example, strong
consecutive interactions occurred within the widely conserved purine biosynthetic
pathway with enzymes eluting in two peaks (for example, PAICS, GART), one
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Network Reactome Reaction or Metabolic Pathway
EEF1B2 EEF1A1 1.00 0 Signaling REACT 67.1
EEF1D EEF1A1 1.00 0 Signaling REACT 67.1
PDS5B PDS5A 1.00 1 Signaling REACT 150250.3
UBE2I SAE1 0.85 0 Signaling REACT 163816.3 REACT 163643.3REACT 163963.3
EIF5 EIF2S2 0.73 0 Signaling REACT 1060.1 REACT 656.1
EEF1A1 EEF2 0.68 1 Signaling REACT 1937.1
EIF5 EIF3I 0.46 0 Signaling REACT 1060.1 REACT 656.1
EIF5 EIF2S1 0.46 0 Signaling REACT 1060.1 REACT 656.1
UBE2I UBA2 0.37 0 Signaling REACT 163816.3 REACT 163643.3REACT 163963.3
RAB8A RAB10 0.27 0 Signaling REACT 147836.3
MAPK1 MAPK3 0.22 0 Signaling REACT 111117.2
EIF3G EIF5 0.20 0 Signaling REACT 1060.1 REACT 656.1
RHOA TRIO 0.13 0 Signaling REACT 10098.1 REACT 19216.3
RAC1 RHOC 0.12 0 Signaling REACT 19137.4
EIF5 EIF3B 0.11 0 Signaling REACT 1060.1 REACT 656.1
EIF4G1 TNKS1BP1 0.09 0 Signaling REACT 20651.2
STAM2 TSG101 0.09 0 Signaling REACT 27272.2
PCNA POLE 0.08 1 Signaling REACT 353.2 REACT 677.2
HADHA HADHB 1.00 0 Metabolic
Mitochondrial beta-oxidation of
long chain fatty acids
TKT TALDO1 0.99 0 Metabolic Nonoxidative pentose phosphate pathway
TKTL2 TALDO1 0.97 0 Metabolic Nonoxidative pentose phosphate pathway
PPAT GART 0.44 0 Metabolic Purine biosynthesis
HIBADH ALDH6A1 0.34 0 Metabolic Catabolism of L-valine
PHGDH PSAT1 0.27 0 Metabolic L-serine synthesis
UAP1 PGM3 0.27 0 Metabolic Amino sugar and nucleotide sugar metabolism
GART PFAS 0.27 0 Metabolic Purine biosynthesis
HSD17B10 ACAA2 0.22 0 Metabolic Amino acid metabolism
LDHA ALDH2 0.16 0 Metabolic Glycolysis and Amino acid metabolism
PYGB GBE1 0.16 0 Metabolic Starch and sucrose metabolism
TKT RPE 0.14 0 Metabolic Nonoxidative pentose phosphate pathway
LDHA ALDH1B1 0.14 0 Metabolic Glycolysis
PYGL GBE1 0.13 0 Metabolic Starch and sucrose metabolism
ACAT1 ACAA2 0.13 0 Metabolic Fatty acid degradation,Valine, leucine andisoleucine degradation
ADSL ATIC 0.11 0 Metabolic Purine biosynthesis
PYGM GBE1 0.08 0 Metabolic Starch and sucrose metabolism
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coincident with the prior enzyme and the second with the downstream enzyme,
suggestive of substrate channeling (Ovádi, 1995) (Figure 4.13).
Figure 4.13: Interactions between consecutive pathway and metabolic pairs. a,
Enrichment (permutation test P value) for interactions among sequential pathway
components and metabolic enzymes relative to shuffled controls (n refers to enzyme
index, where n,n+1 denotes sequential enzymes, n,n+2 sequential-but-one, and so
on, as described in Section 4.5.) b, Metabolic channelling as opposed to traditional
(typical) two-step cascade model. c, Conserved interactions among consecutively
acting enzymes involved in purine biosynthesis (two representative co-fractionation




While it might have been expected that identifying accurate and sensible
protein complexes from protein interaction networks would be a replicable and
straightforward process, this does not turn out to be the case. Clustering graphs is
by no means a solved research problem. The various approaches previously used,
when applied to this set of identified protein interactions, suffered in my hands
from some combination of redundancy, high sensitivity to input interactions, lack
of participation in multiple complexes, over-collapse of large complexes, and lack
of accuracy against gold standard curated human complexes. Through extensive
exploration with the help of the automated clustering and parameter exploration
pipeline I developed, I succeeded in establishing a clustering approach that resolved
the various shortcomings of prior methods. I used this new approach to derive a set
of nearly 1,000 conserved animal complexes, and validated them computationally
and many of them, with the help of colleagues, experimentally. These complexes




I found and jointly optimized the key parameters that drove clustering vari-
ation and performance. I also found a combination of parameters that satisfied the
average non-overlap redundancy constraint and maximized the maximum matching
ratio and sensitivity values. ClusterOne employs two main parameters—a mini-
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mum density for identified complexes and a penalty term to slow agglomeration.
Optimization resulted in selecting values of 0.35 and 1.0, respectively. In compar-
ing balanced and unbalanced training sets in the scoring of protein pairs, clustering
results were sensitive to the rate of falloff of these pairwise scores, so a scaling
parameter was developed. and was applied in the step before clustering. Since I
used an unbalanced training set for better performance, this parameter was 0.20.
MCL has a single key parameter, called inflation or I, optimized to be a value of 3.0
here. Finally, the number of high pairwise protein co-complex scores provided as
input to the clustering process affected the sensitivity and coverage of the resulting
map of complexes. The optimal value was found to be 1.0% of the pairwise protein
co-membership scores or 9,989 scored pairs. Following identification of strong and
significant complexes, a larger set of high-scoring protein interactions (10% of the
interactions with biochemical evidence or 99,888 pairs) were used to define the sig-
nificant interactions observed within the identified complexes. These interactions
form the edges in the final complex map.
4.5.2 Incorporation of high-confidence interactions
When very high confidence co-complex associations were excluded by the
clustering process, I incorporated them back into the map using the following ap-
proach. First, interactions were judged high-confidence for a score >0.9 in the
cross-validated precision-recall PPI evaluation, which yielded 283 additional inter-
actions for inclusion in the map. Second, I re-ranked the top 20,000 interactions
using a selected threshold from the precision-recall curve by the total number of
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biochemical separations in which the protein pair was assigned a high (>0.5) corre-
lation score. I selected all interactions from this set having 20 or more high-scoring
fractionations, yielding 239 interactions for inclusion. The union of these two sets
yielded a total of 507 additional, previously excluded interactions for inclusion in
the map. A final single round of clustering using MCL was applied with the same
parameters applied in stage two of the clustering process (I = 3.0). The resulting
complexes were added to the map, including pairwise interactions excluded from
larger complexes. Finally, redundant complexes were merged if either 1) the com-
plex pair exceeded the Bader-Hogue overlap threshold of 0.55 as described above
or 2) the smaller of the two complexes had more than four members in which all or
all-but-one were a subset of a larger complex.
4.5.3 Analysis of consecutively acting signal transduction and metabolic en-
zyme interactions
In order to test comprehensively for consecutively acting, putatively in-
teracting proteins across cellular pathways in general, proteins in signal trans-
duction and other non-metabolic pathways were assembled from the Reactome
database (Croft et al., 2014), requiring annotations associated with the term “reac-
tion” while excluding interactors related by the terms “direct complex” and “indi-
rect complex”, resulting in 32,703 sequentially acting proteins in cellular pathways,
including in signal transduction, e.g., G-protein and MAPK cascades. In order to
ask specifically whether sequential metabolic enzymes were enriched for interac-
tions, I defined our set of confident sequential enzymes as the intersection of se-
quential pairs found in processing two comprehensive human metabolic networks,
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Recon2 (v02) (Thiele et al., 2013) and KEGG (Kanehisa and Goto, 2000, down-
loaded July 27, 2013). For Recon2, I excluded 36 common metabolites, available
in Table 4.2. The intersection of these two sets of sequential interactions yielded
647 confident sequential metabolic enzymes.








ATP(4-) Nicotinamide adenine dinucleotide
Bicarbonate Nicotinamide adenine dinucleotide - reduced
CMP Nicotinamide adenine dinucleotide phosphate




Flavin adenine dinucleotide oxidized Sodium
Flavin adenine dinucleotide reduced UDP
GDP UDP(3-)
GDP(3-) water
Both pathway sets (general cellular pathways and metabolic enzyme path-
ways) were then analyzed in the same fashion, detailed here for the metabolic case:
I first asked whether these pairs of sequential enzymes were enriched for higher co-
complex scores, according to the output of our integrative machine learning process
of identifying interactions, compared to a reshuffled set of false interactions formed
from the same set of enzymes. Using a two-sample KS test, I calculated the p-value
that the distribution of interaction scores from our sequential enzyme set differed
from the distribution of scores from reshuffled negative interactions, finding indeed
a significant enrichment for higher scores (p < 0.022). I repeated the analysis
for enzymes separated by two steps, by three or four steps, and by an independent
76
reshuffled set of enzyme pairs, finding decreasing significance of enrichment for
higher scores in each case, as shown in Figure 4.13, a. Among the high-confidence
interaction partners, I identified 17 examples of sequentially acting, physically in-
teracting enzyme pairs, including six falling into two respective pathways of three
pairs each: the purine biosynthetic pathway, and the pentose phosphate pathway.
The consecutively acting, co-complex Reactome pathway and Re-
con/KEGG enzyme pairs are listed in Table 4.1.
4.6 Open science
Conserved complexes are available for download4. Code for the full clus-
tering pipeline, clustering evaluation, and generation of many figures is publicly
available online5.




Conclusions and future directions
The sequencing of entire genomes provided the parts lists for biological re-
search. These sequences can be compared across near and distant species to reveal
evolutionary principles and to distribute knowledge gained in one species across
evolutionary distances, which among other things significantly enables model or-
ganism research to directly shed light on human biology and disease. This inte-
grated and comprehensive understanding of the function of a growing number of
genes and proteins also advances our ability to interpret diseases and other differ-
ences between human individuals in terms of their genetic basis, stimulating the
emerging and growing era of personalized medicine. However, this view of biol-
ogy lacks mechanistic insight into the underlying factors, such as the regulatory
relationships, signaling pathways, and the multi-protein machines that provide a
mechanistic basis for a genes physiological effects. The conserved interactions and
complexes described in this thesis are a step towards filling this gap. The shared
code and methods enable others to apply this approach and build on it to map in-
teractions across broad swathes of biology, uncovering machines and relationships
that reveal novel mechanistic and physiological insights to increase our predictive
understanding of the link from genes to phenotype and physiological effects.
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Beyond these direct impact of undertaking this work and absorbing the bi-
ological knowledge in developing a useful lens into biology, I have learned a few
important lessons I will carry forward with me in my ambitions to have the largest
positive impact I can on the advancement of biological research towards under-
standing and treating all the limitations and failures of our amazing, but fragile,
human bodies.
5.1 Large-scale, unbiased data
Biologists elucidated our current understanding of biology through low-
throughput, rigorous investigations of diverse biological systems, often supported
by the incredible power of human intuition. These investigations have historically
focused predominantly on a small number of genes and proteins, a small enough set
to fit in a simple cartoon diagram, and have employed a vast array of biochemical
and molecular biology approaches to uncover the often highly complex relation-
ships among them. Without such data gathered using these methods, the interpre-
tation and validity of unbiased and high-throughput data sets would be difficult or
impossible to determine. However, once such well-established knowledge exists,
recent advances in experimental tools and methods in computational capacity and
software are well-positioned to greatly expand its breadth and precision in biomed-
ical research.
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5.2 Functional basis for interrelatedness
The interrelatedness of different biological processes means that, in seeking
to predict, for instance, protein complexes, you may consider using other types of
biological relationships that at first glance appear unrelated. Nearly all aspects of
biology relate to function, which is one way of wording the principle of guilt-by-
association as applied to biology, indicating that one kind of biological relationship
might be useful in predicting many other types of biological relationships (Wang
2010). This is especially true in the context of modern machine learning methods,
which are excellent at distinguishing features that are predictive of a desired output
from those that are not.
5.3 Orthogonal measurements in changing biological contexts
When the mutual information content between two data sets or two data
sources is high, the amount of new understanding that can be uncovered is limited.
For instance, identifying nearly 1,000 complexes based on co-fractionation exper-
iments would be very challenging with a size-matched data set consisting only of
experiments using the same fractionation method, the same cell type or tissue, the
same species, and the same experimental conditions. Asking this same experi-
mental question in highly varied biological contexts can dramatically increase our
ability to extract meaningful biological insights.
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5.4 Open-source computational tools in proteomics and net-
work biology
The continued advances in genomics has convinced a growing portion of
new and existing generations of biologists to the value of a systems perspective in
biology. Biologists and labs integrating computational approaches to model and
predict biology, especially at the genome level, continue to make rapid advance-
ments in the field and benefit enormously from the plethora of tools available for
everything from aligning genomes to interpreting genome-wide RNA-seq data sets.
Due to the smaller relative size and newness of the field, proteomics and network
biology lack the level of computational infrastructure available in genomics, which
impedes progress to understand biological relationships and networks. It is my hope
that my use of open-source tools whenever possible and publication of the meth-
ods and code for mass spectrometry data processing, data integration and inference,
clustering, analysis and visualization will serve both to improve the suite of avail-
able open-source tools and methods and also to encourage others to develop and
share open-source tools for these and related problems in the field.
5.5 Computational biologists at a point of high leverage
We are in the middle of an explosion of advancement in computational re-
sources and techniques, and interest is high in computer science, software engineer-
ing, machine learning and artificial intelligence. While this explosion has undoubt-
edly led to steps forward in computational methods within biology, the vast major-
ity of youths and adults with advanced computational skills never find themselves
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working on or even considering problems relating to biology or medical research.
In my opinion, this problem should be of utmost concern to those wishing to ad-
vance biological and medical research. This opinion has guided my career path into
industry. I believe it may be possible to significantly increase the number and attrac-
tiveness of opportunities for computational scientists without a biology background
to acquire one more easily, by providing avenues of entry into the field consisting of
challenging and compelling problems that are approachable with minimal domain
knowledge. As exciting problems and gifted co-workers are, in my view, one of
the main drivers of career choices among the most ambitious and gifted computa-
tional workers, I hope this approach can contribute to the growth of a virtuous cycle,
attracting more and more of the best and brightest to problems in the field.
5.6 The new way, not like the old way
Only 15 years ago, we saw the first draft of the human genome. The subse-
quent progress in biological understanding, if not yet medical treatments, has been
phenomenal. Now we have single-cell genomes shedding light on the heterogene-
ity of tumors, and single-cell transcriptomes revealing the differentiation path of
cellular networks. With further advances in co-fractionation and other approaches,
we are on our way to establish personalized and, eventually, single-cell interac-
tion networks. Our ability to generate rich biological data has grown tremendously
and continues to increase rapidly. Many in the field complain today, as they have
for decades, that we are drowning in a sea of biological data, far more of it than
we even yet know how to properly analyze, much less fully exploit (Roos, 2001;
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Brooksbank, Cameron, and Thornton, 2005; Marx, 2013). The mountain of mass
spectrometry data generated for the studies described here is a perfect example. Our
analyses only tapped a minuscule fraction of the information available in these ex-
periments. If only we had more insight into the best questions to ask, more ideas for
how to leverage this data to support of other lines of research, and more computa-
tional resources and talent to apply to the problem, I have little doubt the discoveries
described here would be eclipsed many times over.
Biologists have started to see signs of the rising tide, but have yet to fully
appreciate the enormity of the approaching wave that accompanies the coming com-
putational revolution. A decade ago, a personal assistant on everyones phone capa-
ble of taking notes, sending emails, and scheduling meetings was a distant dream.
Cars capable of driving themselves in nearly all conditions were widely perceived
as science fiction or generations away, dreams of naive artificial intelligence and
machine learning researchers and enthusiasts. And yet, rapid advances in machine
learning have brought the first to fruition and the second to within a few years reach.
I hope biologists will understand the connections between these and other advances
in artificial intelligence and machine learning, as these connections foretell major
changes coming to the field in the coming decade.
How do genomes, transcriptomes, protein interactions, genetic interactions,
regulatory networks, chemogenomics, and other big data subfields of systems bi-
ology all fit together to drive progress on many fronts in biology and medical re-
search? I do not know the answer, but I expect we will likely discover it in the
coming decade. I predict that computational biologists with a combination of in-
83
tense scientific rigor and intimate familiarity with the descendants of today’s cutting
edge machine learning methods will lead the way.
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